MedPath

Yonsei University

Yonsei University logo
πŸ‡°πŸ‡·South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Comparison of Dexamethasone Added to Ropivacaine and Ropivacaine Alone in Caudal Analgesia in Children Undergoing Orchiopexy

Not Applicable
Completed
Conditions
Cryptorchidism
Interventions
Procedure: Caudal block
First Posted Date
2012-05-24
Last Posted Date
2013-07-09
Lead Sponsor
Yonsei University
Target Recruit Count
80
Registration Number
NCT01604915
Locations
πŸ‡°πŸ‡·

Severance hospital, Seoul, Korea, Republic of

Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block

Not Applicable
Conditions
CRPS
Herpes Zoster
Interventions
Other: supine extended position of the neck
First Posted Date
2012-05-18
Last Posted Date
2013-01-24
Lead Sponsor
Yonsei University
Target Recruit Count
42
Registration Number
NCT01601925
Locations
πŸ‡°πŸ‡·

Gangnam Severance hospital, Seoul, Korea, Republic of

Effects of Minocycline on Cytokine Levels in Severe Meibomian Gland Dysfunction

Not Applicable
Completed
Conditions
Meibomian Gland Dysfunction
Interventions
Drug: oral minocycline hydrochloride treatment
First Posted Date
2012-05-17
Last Posted Date
2014-03-05
Lead Sponsor
Yonsei University
Target Recruit Count
46
Registration Number
NCT01600625
Locations
πŸ‡°πŸ‡·

Severance Hospital, Seoul, Korea, Republic of

Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections

Phase 4
Completed
Conditions
Thyroid-associated Ophthalmopathy
Interventions
First Posted Date
2012-05-16
Last Posted Date
2015-01-28
Lead Sponsor
Yonsei University
Target Recruit Count
50
Registration Number
NCT01599273
Locations
πŸ‡°πŸ‡·

Severance hospital, Seoul, Korea, Republic of

Antiviral Efficacy of Switching to ETV Plus TDF

Phase 4
Conditions
Chronic Hepatitis B
Interventions
Drug: Group A (Zeffix, Sebivo, Hepsera)
Drug: Group B (Baraclude, Viread)
First Posted Date
2012-05-15
Last Posted Date
2014-01-31
Lead Sponsor
Yonsei University
Target Recruit Count
104
Registration Number
NCT01597934

Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy

Phase 4
Conditions
Chronic Hepatitis B
Interventions
Drug: Switching from adefovir (10mg/day) to tenofovir (300mg/day)
First Posted Date
2012-05-10
Last Posted Date
2012-05-10
Lead Sponsor
Yonsei University
Target Recruit Count
124
Registration Number
NCT01595633
Locations
πŸ‡°πŸ‡·

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection

Phase 4
Conditions
Chronic Hepatitis B
Interventions
First Posted Date
2012-05-09
Last Posted Date
2014-01-31
Lead Sponsor
Yonsei University
Target Recruit Count
90
Registration Number
NCT01594905

The Effects of Dexmedetomidine and Tracheal Intubation on Heart Rate Variability and QTc Interval

Not Applicable
Completed
Conditions
Anesthesia, General
Interventions
Drug: 0.5 mcg/kg IV infusion for 10 min, 1.0 mcg/kg IV infusion for 10 min
First Posted Date
2012-04-25
Last Posted Date
2019-02-26
Lead Sponsor
Yonsei University
Target Recruit Count
80
Registration Number
NCT01584570
Locations
πŸ‡°πŸ‡·

Severance hospital, Seoul, Korea, Republic of

Assessment of Stent Malapposition and Neointimal Coverage on Optical coHerence Tomography at Post-procedure and 3 Months After Platinum Chromium Alloy Of the Elementβ„’ Stent Implantation

Phase 4
Conditions
Coronary Artery Disease
Interventions
Device: Promus Element everolimus eluting coronary stent
Device: Xience Prime everolimus eluting coronary stent
First Posted Date
2012-04-20
Last Posted Date
2012-04-20
Lead Sponsor
Yonsei University
Target Recruit Count
100
Registration Number
NCT01581515
Locations
πŸ‡°πŸ‡·

Severance Hospital, Seoul, Seodaemun-gu/Sinchon-dong, Korea, Republic of

Randomized Controlled Trial to Evaluate of Dexmedetomidine for the Effect on Operative Visibility in Patients Undergoing Endoscopic Sinus Surgery

Phase 4
Completed
Conditions
Chronic Sinusitis
Interventions
First Posted Date
2012-04-02
Last Posted Date
2014-03-05
Lead Sponsor
Yonsei University
Target Recruit Count
66
Registration Number
NCT01569048
Locations
πŸ‡°πŸ‡·

Severance Hospital, Seoul, Korea, Republic of

Β© Copyright 2025. All Rights Reserved by MedPath